I-Ching Sam1, Magelda Montoya2, Chong Long Chua1, Yoke Fun Chan1, Andrew Pastor2, Eva Harris2. 1. Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. 2. Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
Abstract
BACKGROUND: Zika virus (ZIKV) is believed to be endemic in Southeast Asia. However, there have been few Zika cases reported to date in Malaysia, which could be due to high pre-existing levels of population immunity. METHODS: To determine Zika virus (ZIKV) seroprevalence in Kuala Lumpur, Malaysia, 1085 serum samples from 2012, 2014-2015 and 2017 were screened for anti-ZIKV antibodies using a ZIKV NS1 blockade-of-binding assay. Reactive samples were confirmed using neutralization assays against ZIKV and the four dengue virus (DENV) serotypes. A sample was possible ZIKV seropositive with a ZIKV 50% neutralization (NT50) titre ≥20. A sample was probable ZIKV seropositive if, in addition, all DENV NT50 titres were <20 or the ZIKV NT50 titre was >4-fold greater than the highest DENV NT50 titre. RESULTS: We found low rates of possible ZIKV seropositivity (3.3% [95% confidence interval {CI} 2.4 to 4.6]) and probable ZIKV seropositivity (0.6% [95% CI 0.3 to 1.4]). Possible ZIKV seropositivity was independently associated with increasing age (odds ratio [OR] 1.04 [95% CI 1.02 to 1.06], p<0.0001) and male gender (OR 3.5 [95% CI 1.5 to 8.6], p=0.005). CONCLUSIONS: The low ZIKV seroprevalence rate, a proxy for population immunity, does not explain the low incidence of Zika in dengue-hyperendemic Kuala Lumpur. Other factors, such as the possible protective effects of pre-existing flavivirus antibodies or reduced transmission by local mosquito vectors, should be explored. Kuala Lumpur is at high risk of a large-scale Zika epidemic.
BACKGROUND:Zika virus (ZIKV) is believed to be endemic in Southeast Asia. However, there have been few Zika cases reported to date in Malaysia, which could be due to high pre-existing levels of population immunity. METHODS: To determine Zika virus (ZIKV) seroprevalence in Kuala Lumpur, Malaysia, 1085 serum samples from 2012, 2014-2015 and 2017 were screened for anti-ZIKV antibodies using a ZIKVNS1 blockade-of-binding assay. Reactive samples were confirmed using neutralization assays against ZIKV and the four dengue virus (DENV) serotypes. A sample was possible ZIKV seropositive with a ZIKV 50% neutralization (NT50) titre ≥20. A sample was probable ZIKV seropositive if, in addition, all DENV NT50 titres were <20 or the ZIKV NT50 titre was >4-fold greater than the highest DENV NT50 titre. RESULTS: We found low rates of possible ZIKV seropositivity (3.3% [95% confidence interval {CI} 2.4 to 4.6]) and probable ZIKV seropositivity (0.6% [95% CI 0.3 to 1.4]). Possible ZIKV seropositivity was independently associated with increasing age (odds ratio [OR] 1.04 [95% CI 1.02 to 1.06], p<0.0001) and male gender (OR 3.5 [95% CI 1.5 to 8.6], p=0.005). CONCLUSIONS: The low ZIKV seroprevalence rate, a proxy for population immunity, does not explain the low incidence of Zika in dengue-hyperendemic Kuala Lumpur. Other factors, such as the possible protective effects of pre-existing flavivirus antibodies or reduced transmission by local mosquito vectors, should be explored. Kuala Lumpur is at high risk of a large-scale Zika epidemic.
Authors: Rahman G M Saifur; Ahmad Abu Hassan; Hamady Dieng; Hamdan Ahmad; M Rawi Che Salmah; Tomomitsu Satho; Ahmad Ramli Saad; Ronald Enrique Morales Vargas Journal: J Am Mosq Control Assoc Date: 2012-06 Impact factor: 0.917
Authors: Magelda Montoya; Matthew Collins; Wanwisa Dejnirattisai; Leah C Katzelnick; Henry Puerta-Guardo; Ramesh Jadi; Samuel Schildhauer; Piyada Supasa; Sirijitt Vasanawathana; Prida Malasit; Juthathip Mongkolsapaya; Aruna D de Silva; Hasitha Tissera; Angel Balmaseda; Gavin Screaton; Aravinda M de Silva; Eva Harris Journal: J Infect Dis Date: 2018-07-13 Impact factor: 5.226
Authors: Matthew H Collins; Eileen McGowan; Ramesh Jadi; Ellen Young; Cesar A Lopez; Ralph S Baric; Helen M Lazear; Aravinda M de Silva Journal: Emerg Infect Dis Date: 2017-05 Impact factor: 6.883
Authors: Chong Long Chua; Yoke Fun Chan; Eva S G Soh Andu; Jeffrine J Rovie-Ryan; Frankie Thomas Sitam; Khebir Verasahib; I Ching Sam Journal: Emerg Infect Dis Date: 2019-02 Impact factor: 6.883
Authors: Hooi-Yuen Khoo; Hai-Yen Lee; Chee-Sieng Khor; Kim-Kee Tan; Mohd Rohaizat Bin Hassan; Chin Mun Wong; Hani Kartini Agustar; Nadia Aqilla Samsusah; Syed Sharizman Syed Abdul Rahim; Mohd Saffree Bin Jeffree; Nur Athirah Yusof; Noor Ain Haron; Zarina Binti Amin; Rozita Hod; Sazaly AbuBakar Journal: Am J Trop Med Hyg Date: 2022-07-25 Impact factor: 3.707
Authors: Guilherme S Ribeiro; Gabriel L Hamer; Mawlouth Diallo; Uriel Kitron; Albert I Ko; Scott C Weaver Journal: Curr Opin Virol Date: 2020-03-17 Impact factor: 7.090
Authors: Sonja E Leonhard; Cheng Yin Tan; Annemiek A van der Eijk; Ricardo R Reisin; Suzanne C Franken; Ruth Huizinga; Samuel Arends; Manou R Batstra; Selma M Bezerra Jeronimo; Judith Drenthen; Laura de Koning; Luciana Leon Cejas; Cintia Marchesoni; Wilson Marques; Nortina Shahrizaila; Dardo F Casas; Andrea Sotelo; Belen Tillard; Mario-Emilio Dourado; Bart C Jacobs Journal: J Peripher Nerv Syst Date: 2021-09-30 Impact factor: 5.188